TY - JOUR
AB - [Eur Heart J (2017); doi:10.1093/eurheartj/ehx549]. The authors of the above article wish to inform readers that the following correction has been made post-publication: figure 4 has been corrected to amend the text ‘refer to Box 3’ to ‘refer to text’. Published on behalf of the European Society of Cardiology. All rights reserved. © The Author 2017. For permissions, please email: journals.permissions@oup.com. This article is published and distributed under the terms of the Oxford University Press, Standard Journals Publication Model (https://academic.oup.com/journals/pages/about_us/legal/notices)
TI - Corrigendum to: 2017 Update of ESC/EAS Task Force on practical clinical guidance for proprotein convertase subtilisin/kexin type 9 inhibition in patients with atherosclerotic cardiovascular disease or in familial hypercholesterolaemia
JO - European Heart Journal
DO - 10.1093/eurheartj/ehx648
DA - 2017-11-24
UR - https://www.deepdyve.com/lp/oxford-university-press/corrigendum-to-2017-update-of-esc-eas-task-force-on-practical-clinical-Qelf89V0gg
SP - 2105
EP - 2105
VL - 39
IS - 22
DP - DeepDyve
ER -